powered exoskeletons: Whether to use powered exoskeletons for exercise rehabilitation
Study summary
Systematic and professional rehabilitation training is generally effective for patients with lower limb dyskinesia, but most of them lose the chance of recovery due to failure to receive systematic rehabilitation treatment. Our team has developed an intelligent power armor for patients with lower limb motor dysfunction, which can assist patients to complete high-quality rehabilitation training. In order to evaluate the safety and efficacy of the Smart Power Armor for post-surgical spine patients, and to provide data support for a confirmatory clinical study, we designed a single-center, prospective, randomized controlled study to compare the level of recovery of lower limb motor function in patients with different rehabilitation strategies.
Eligibility
Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria:
* Age 18-70 years old;
* Spinal surgery within 1 year due to degeneration, tumor, trauma or other reasons, postoperative motor disorders of both lower limbs, such as muscle weakness (3-5 level reduction), increased muscle tone, gait incoordination caused by deep sensory loss, etc.;
* The patient does not have a plan to rehabilitate in a specialized rehabilitation hospital, and plans to rehabilitate at home;
Exclusion Criteria:
* Short expected survival from malignant diseases;
* Muscle strength is less than grade 3, and the muscles of both lower limbs are severely atrophied;
* Suffering from other neurological diseases;
* Planned to undergo other surgeries within 3 months;
* Unable to cooperate with the transmission power external armor or cooperate with the rehabilitation training due to the physical condition;
Primary outcome measure(s)
Six-minute walk test — 3 months meter; distance participants walked as fast as possible in a flat corridor in six minutes
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.